Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 8/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.61 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.61 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.61 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.61 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.61 |
| ▸ | GABRP | O00591 | 1/20 | 0.61 |
| ▸ | GABRD | O14764 | 1/20 | 0.61 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.61 |
| ▸ | ALB | P02768 | 1/20 | 0.61 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.61 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Medazepam SCHEMBL29642025 | 1.00 | OPRK1 (1.00) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| Medazepam SCHEMBL11658148 | 1.00 | OPRK1 (1.00) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| Medazepam SCHEMBL78352 | 0.99 | OPRK1 (0.97) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| SCHEMBL14018729 | 0.92 | OPRK1 (0.84) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| SCHEMBL9472878 | 0.86 | OPRK1 (0.76) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| Medazepam SCHEMBL30366342 | 0.86 | OPRK1 (0.76) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| SCHEMBL11680057 | 0.86 | OPRK1 (0.76) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| SCHEMBL9472170 | 0.86 | OPRK1 (0.75) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| SCHEMBL3235774 | 0.84 | OPRK1 (0.73) | OPRK1PDE4DNR1I2ADORA3HTR2C | |
| SCHEMBL11683117 | 0.83 | OPRK1 (0.71) | OPRK1PDE4DNR1I2ADORA3HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7153 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368700-A1 | NOVEL PEPTIDE FOR TREATING AN INFECTIOUS DISEASE OR CONDITION | OMNIX MEDICAL LTD (IL) | 2025-12-04 | — | — | US | claimed |
| US-20250313597-A1 | NOVEL PEPTIDE FOR TREATING AN INFECTIOUS DISEASE OR CONDITION | OMNIX MEDICAL LTD. (IL) | 2025-10-09 | — | — | US | claimed |
| US-20250277002-A1 | ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE | PEPTILOGICS, INC. | 2025-09-04 | — | — | US | claimed |
| US-20250179064-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS LLC | 2025-06-05 | — | — | US | claimed |
| EP-4547696-A1 | NOVEL PEPTIDE FOR TREATING AN INFECTIOUS DISEASE OR CONDITION | Omnix Medical Ltd. (IL) | 2025-05-07 | — | — | EP | claimed |
| EP-4547697-A1 | NOVEL PEPTIDE FOR TREATING AN INFECTIOUS DISEASE OR CONDITION | Omnix Medical Ltd. (IL) | 2025-05-07 | — | — | EP | claimed |
| CN-119522109-A | Compositions for intermittent administration of calcineurin inhibitors | 特雷弗·克利 | 2025-02-25 | — | — | CN | claimed |
| CN-119325617-A | System and method for assessing disease burden and progression | 普罗热尼奇制药公司 | 2025-01-17 | — | — | CN | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| EP-4422607-A1 | ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| EP-0240904-A2 | Process for the preparation of solid pharmaceutical forms | BASF Aktiengesellschaft (DE) | 1987-10-14 | — | — | EP | claimed |
| EP-0216555-A2 | Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections | BTG INTERNATIONAL LIMITED (GB) | 1987-04-01 | — | — | EP | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| EP-0050487-A1 | Pharmaceutical compositions comprising a benzodiazepine drug and a phenanthridine derivative | PFIZER INC. (US) | 1982-04-28 | — | — | EP | claimed |
| US-4320124-A | ANALGESICS | PFIZER INC. (US) | 1982-03-16 | — | — | US | claimed |
| US-4316897-A | TRANQUILIZERS | HOFFMANN-LA ROCHE INC. (US) | 1982-02-23 | — | — | US | claimed |
| EP-0025546-A2 | Therapeutical use of tranquillizing benzodiazepine derivatives and mixtures containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-03-25 | — | — | EP | claimed |
| US-4155904-A | Process for the preparation of 1,4-benzo-diazepines and 1,4-benzodiazepinones | SCHERING CORPORATION (US) | 1979-05-22 | — | — | US | claimed |
| US-4044003-A | Process for preparing 1,4-benzodiazepines | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-23 | — | — | US | claimed |
| US-4028467-A | Analgesic compositions comprising levo-propoxyphene and benzo diazepine and process | BERGER FRANK M | 1977-06-07 | — | — | US | claimed |